Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2018
published in
- JAMA oncology Journal
has subject area
- Anaplastic Lymphoma Kinase
- Antineoplastic Agents
- Clinical Trials, Phase III as Topic
- Crizotinib
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms
- Molecular Targeted Therapy
- Multicenter Studies as Topic
- Neoplasm Proteins
- Neoplasms
- Progression-Free Survival
- Protein Kinase Inhibitors
- Randomized Controlled Trials as Topic
- Time Factors
- Treatment Outcome